非感染性主动脉内移植物失败后手术取出的长期结局
择期组30天死亡率为2.4%,急性组为18.2%;中位随访42.5个月,择期组5年生存率95%,急性组58%。结论认为开放取出在选定患者中是可行且持久的治疗选择。
要点
- 择期取出者30天死亡率2.4%,急性取出者18.2%。
- 5年生存率择期组95%,急性组58%。
- 5年免于再干预率择期组90%,急性组85%。
核心结论
- 非感染性EVAR失败后开放手术取出在选定患者中是可行且持久的治疗选择,尤其择期病例结局良好。
主要发现
- 主要取出指征为1a型内漏,占88.5%。
- 30天死亡率择期组2.4%,急性组18.2%。
- 中位随访42.5个月,估算5年生存率择期组95%,急性组58%。
- 5年免于再干预率择期组90%,急性组85%。
- 最常取出的内移植物为Nellix。
临床怎么用
- 对EVAR失败且腔内挽救不可行(如解剖困难或入路问题)的非感染患者,可考虑开放取出。
- 及时识别移植物失败并优化患者状态,有助于提高择期取出的安全性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Open surgical explantation after failed endovascular aortic repair (EVAR) may be required in selected cases, particularly in patients with type 1a endoleak when endovascular salvage is unfeasible. However, literature on long-term outcomes remains limited. Our study aims to investigate the short- and long-term outcomes of patients who underwent surgical explantation of failed noninfected aortic endograft. METHODS: In this retrospective study, patients who underwent open explantation of a failed, noninfected infrarenal EVAR between January 2016 and December 2024 at a tertiary referral center were included. Data on baseline characteristics, initial EVAR, explantation, and outcomes were analyzed. Our primary endpoint was long-term mortality and our secondary endpoints included 30-day adverse events. Kaplan-Meier survival curves were used to visualize the long-term outcomes. RESULTS: Fifty-two patients were included (41 elective and 11 acute explantation). The primary indication for explantation was type 1a endoleak (88.5%). The 30-day mortality was 2.4% in the elective group and 18.2% in the acute group. Median follow-up was 42.5 months. Estimated 5-year survival was 95% in the elective group and 58% in the acute group. Freedom from reintervention at 5 years was 90% (elective) and 85% (acute). The Nellix endograft was most frequently explanted. CONCLUSION: Open explantation of failed, noninfected EVAR is a viable option with favorable outcomes in selected patients. Elective cases show excellent survival and low complication rates, underscoring the importance of timely identification of failure and patient optimization. These findings support explantation as a durable treatment option in selected patients when endovascular alternatives are unsuitable (i.e. anatomic difficulties or access problems).
引用
- Liesker DJ, van Lammeren GW, Scholten E, et al. Long-Term Outcomes of Surgical Explantation for Failed Noninfected Aortic Endografts. Ann Vasc Surg. 2026. PMID: 41692159. doi:10.1016/j.avsg.2026.02.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。